Oral re-vaccination of Eurasian wild boar with Mycobacterium bovis BCG yields a strong protective response against challenge with a field strain

BACKGROUND: Field vaccination trials with Mycobacterium bovis BCG, an attenuated mutant of M. bovis, are ongoing in Spain, where the Eurasian wild boar (Sus scrofa) is regarded as the main driver of animal tuberculosis (TB). The oral baiting strategy consists in deploying vaccine baits twice each su...

Descripción completa

Detalles Bibliográficos
Autores principales: Gortazar, Christian, Beltrán-Beck, Beatriz, Garrido, Joseba M, Aranaz, Alicia, Sevilla, Iker A, Boadella, Mariana, Lyashchenko, Konstantin P, Galindo, Ruth C, Montoro, Vidal, Domínguez, Lucas, Juste, Ramón, de la Fuente, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005810/
https://www.ncbi.nlm.nih.gov/pubmed/24766746
http://dx.doi.org/10.1186/1746-6148-10-96

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005810/
https://www.ncbi.nlm.nih.gov/pubmed/24766746
http://dx.doi.org/10.1186/1746-6148-10-96

Ejemplares similares